Encelle Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Encelle General Information

Description

Developer of therapeutic and clinical development products to repair or regenerate diseased or damaged tissues. The company has developed and patented an injectable biopolymer that is expected to have application for multiple therapeutic indications. Other uses of the company's products include cosmetic surgery, tendon and bone repair, peripheral nerve regeneration and angiogenesis.

Contact Information

Website
www.encelle.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2408 South Charles Boulevard
  • Street 3
  • Greenville, NC 27834
  • United States
+1 (919)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Clinics/Outpatient Services
Acquirer
Resolve Surgical Technologies
Vertical(s)
Life Sciences
Corporate Office
  • 2408 South Charles Boulevard
  • Street 3
  • Greenville, NC 27834
  • United States
+1 (919)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Encelle Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 04-Jun-2007 Completed Generating Revenue
6. Later Stage VC (Series D) 04-Jan-2005 Completed Generating Revenue
5. Grant 14-Jul-2003 Completed Generating Revenue
4. Later Stage VC (Series D) 23-Sep-2002 Completed Generating Revenue
3. Later Stage VC 08-Feb-2002 Completed Product Development
2. Later Stage VC 29-May-2001 $7M $10.5M Completed Product Development
1. Early Stage VC (Series A) 25-May-1997 $3.5M $3.5M Completed Product Development
To view Encelle’s complete valuation and funding history, request access »

Encelle Patents

  • 117

    Total Documents Applications and Grants

  • Total Patents Families

  • 42

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Encelle Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2543255-A1 Methods and compositions for regenerating connective tissue Active 22-Oct-2003
CA-2543255-C Methods and compositions for regenerating connective tissue Inactive 22-Oct-2003
US-20050118230-A1 Crosslinked polypeptide and a long chain carbohydrate as bioactive matrix; bone disorders Inactive 22-Oct-2003
ES-2522575-T3 Bioactive hydrogel compositions for connective tissue regeneration Inactive 22-Oct-2003
AU-2004285480-A1 Bioactive hydrogel compositions for regenerating connective tissue Active 22-Oct-2003 A61L27/52
To view Encelle’s complete patent history, request access »

Encelle Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Band of Angels Angel Group Minority
Coastal Growth Partners Venture Capital Minority
Cordova Ventures Venture Capital Minority
Hibernia Capital Partners Venture Capital Minority
Intersouth Partners Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Encelle FAQs

  • When was Encelle founded?

    Encelle was founded in 1995.

  • Where is Encelle headquartered?

    Encelle is headquartered in Greenville, NC.

  • What industry is Encelle in?

    Encelle’s primary industry is Drug Discovery.

  • Is Encelle a private or public company?

    Encelle is a Private company.

  • What is Encelle’s current revenue?

    The current revenue for Encelle is .

  • How much funding has Encelle raised over time?

    Encelle has raised $17.9M.

  • Who are Encelle’s investors?

    Band of Angels, Coastal Growth Partners, Cordova Ventures, Hibernia Capital Partners, and Intersouth Partners are 5 of 9 investors who have invested in Encelle.

  • When was Encelle acquired?

    Encelle was acquired on 04-Jun-2007.

  • Who acquired Encelle?

    Encelle was acquired by Resolve Surgical Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »